Novocure Ltd (NASDAQ:NVCR)

73.53
Delayed Data
As of 4:00pm ET
 -6.56 / -8.19%
Today’s Change
56.39
Today|||52-Week Range
94.00
-2.06%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$8.4B

Company Description

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Contact Information

NovoCure Ltd.
No. 4 The Forum
St. Helier Jersey JE2 4UF
P:441534756700
Investor Relations:
(610) 723-7427

Employees

Shareholders

Mutual fund holders56.70%
Individual stakeholders35.05%
Other institutional24.04%

Top Executives

Asaf DanzigerChief Executive Officer & Director
Wilhelmus C. M. GroenhuysenChief Operating Officer
Ashley CordovaChief Financial Officer
Uri WeinbergChief Science Officer
Ely BenaimChief Medical Officer